Case Report
Copyright ©The Author(s) 2023.
World J Clin Cases. Jul 26, 2023; 11(21): 5167-5172
Published online Jul 26, 2023. doi: 10.12998/wjcc.v11.i21.5167
Figure 1
Figure 1 Kidney pathology showing crescentic glomerulonephritis and focal fibrinoid necrosis under a light microscope. A: Hematoxylin and eosin staining, 400 × magnification; B: Periodic acid-Schiff staining, 400 × magnification; C: Periodic Schiff-methenamine silver staining, 400 × magnification; D: Masson trichrome staining, 400 × magnification.
Figure 2
Figure 2 Clinical course, proteinuria, serum creatinine, and anti-myeloperoxidase antibody level in our patient. A: Clinical course and laboratory test findings in our patient; B: Trends of 24-h urinary protein, serum creatinine, and anti-myeloperoxidase antibody titer. GC: Glucocorticoids; PE: Plasma exchange; CTX: Cyclophosphamide; MMF: Mycophenolate mofetil; RTX: Rituximab; Scr: Serum creatinine; UP: 24-h urinary protein or urinary protein; Ab: Antibody; MPO: Myeloperoxidase.